Table II.
Group | Nrf2 | HO-1 |
---|---|---|
CG | 0.823±0.016 | 2.621±0.040 |
MG | 1.707±0.029a | 4.086±0.031a |
ELG | 3.375±0.039a-c | 5.472±0.042a-c |
EMG | 5.436±0.052a-d | 7.391±0.056a-d |
EHG | 1.612±0.044a | 4.003±0.039a |
Values are mean ± SD.
aP<0.05 vs. CG;
bP<0.05 vs. MG;
cP<0.05 vs. EHG;
dP<0.05 vs. ELG. HO-1, heme oxygenase-1; Nrf2, nuclear factor-erythroid 2-p45-related factor 2; CG, blank control group; MG, model group; ELG, high oxygen exposure + low etomidate dose group (0.3 mg·kg-1); EMG, high oxygen exposure + moderate etomidate dose group (3.0 mg·kg-1); EHG, high oxygen exposure + high etomidate dose group (10 mg·kg-1).